Efficacy and Safety of Long-Acting Reversible Contraception

被引:117
|
作者
Stoddard, Amy [1 ]
McNicholas, Colleen [1 ]
Peipert, Jeffrey F. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Clin Res, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
INTRAUTERINE SYSTEM MIRENA(R); ETONOGESTREL IMPLANT IMPLANON; CLINICAL-PERFORMANCE; LEVONORGESTREL; DEVICES; WOMEN; IUD; EXPERIENCE; PREGNANCY; INSERTION;
D O I
10.2165/11591290-000000000-00000
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Long-acting reversible contraception (LA RC) includes intrauterine devices (IUDs) and the subdermal implant. These methods are the most effective reversible methods of contraception, and have the additional advantages of being long-lasting, convenient, well liked by users and cost effective. Compared with other user-dependent methods that increase the risk of noncompliance-related method failure, LARC methods can bring 'typical use' failure rates more in line with 'perfect use' failure rates. LARC methods are 'forgettable'; they are not dependent on compliance with a pill-taking regimen, remembering to change a patch or ring, or coming back to the clinician for an injection. LARC method failure rates rival that of tubal sterilization at < 1% for IUDs and the subdermal implant. For these reasons, we believe that IUDs and implants should be offered as first-line contraception for most women. This article provides a review of the LARC methods that are currently available in the US, including their effectiveness, advantages, disadvantages and contraindications. Additionally, we dispel myths and misconceptions regarding IUDs, and address the barriers to LARC use.
引用
收藏
页码:969 / 980
页数:12
相关论文
共 50 条
  • [32] Long-Acting Reversible Contraception: Specific Issues for Adolescents
    Menon, Seema
    PEDIATRICS, 2020, 146 (02)
  • [33] Long-acting reversible contraception by effervescent microneedle patch
    Li, Wei
    Tang, Jie
    Terry, Richard N.
    Li, Song
    Brunie, Aurelie
    Callahan, Rebecca L.
    Noel, Richard K.
    Rodriguez, Carlos A.
    Schwendeman, Steven P.
    Prausnitz, Mark R.
    SCIENCE ADVANCES, 2019, 5 (11)
  • [34] Contextualizing barriers to long-acting reversible contraception in Delaware
    Berndt, Virginia Kuulei
    Bell, Ann, V
    CONTRACEPTION, 2021, 103 (06) : 439 - 443
  • [35] Long-acting contraception
    Thomas, MA
    ENDOCRINOLOGIST, 2001, 11 (02): : 131 - 136
  • [36] Obstetrician-Gynecologists and contraception: long-acting reversible contraception practices and education
    Luchowski, Alicia T.
    Anderson, Britta L.
    Power, Michael L.
    Raglan, Greta B.
    Espey, Eve
    Schulkin, Jay
    CONTRACEPTION, 2014, 89 (06) : 578 - 583
  • [37] Increasing Access to Contraception: Examining Barriers and Facilitators of Long-Acting Reversible Contraception
    Kroelinger, Charlan D.
    Pagano, H. Pamela
    DeSisto, Carla L.
    Estrich, Cameron
    Romero, Lisa
    Pliska, Ellen
    Akbarali, Sanaa
    Velonis, Alisa
    Cox, Shanna
    JOURNAL OF WOMENS HEALTH, 2024, 33 (01) : 52 - 61
  • [38] Long-acting reversible contraception: Who, what, when, and how
    Kolman, Karyn B.
    Hadley, Susan K.
    Jordahliafrato, Melody A.
    JOURNAL OF FAMILY PRACTICE, 2015, 64 (08): : 479 - 484
  • [39] Immediate Postpartum Long-Acting Reversible Contraception Uptake and Outcomes
    Holland, Kelsey
    Mastronardi, Alicia
    Young, Megan
    Zite, Nikki
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 7S - 7S
  • [40] Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
    Saavedra-Avendano, Biani
    Andrade-Romo, Zafiro
    Rodriguez, Maria I.
    Darney, Blair G.
    MATERNAL AND CHILD HEALTH JOURNAL, 2017, 21 (09) : 1724 - 1733